Study register · detail
Clear benefit
GRADE
High
23 citations
Samplek = 18 Studien
n = 33.380 Pat.
n = 33.380 Pat.
DurationLongitudinal studies with…
ControlNo cannabis use
EndpointAnxiety disorders/anxiety…
Blindingunklar
DesignMeta-Analyse
Key finding
Adolescent cannabis use is associated with increased risk for later anxiety disorders and anxiety symptoms (OR = 2.14).
Summary
SR + meta-analysis across k=18 longitudinal studies (n=33.380) on adolescent cannabis use and later anxiety outcomes; meta-analysis of k=6 studies shows increased risk for later anxiety disorders (OR=2.14, 95% CI: 1.37-3.36, p<0.01). Qualitative synthesis of k=12 further studies: 9 of 12 found a significant association between adolescent cannabis use and later anxiety symptoms.
P
PopulationAdolescents with cannabis use, pooled N=33.380 from 18 longitudinal studies
I
InterventionCannabis use in adolescence
C
ControlNo cannabis use
O
OutcomeSignificant association between cannabis use in adolescence and later anxiety disorders (OR=2,14; 95%-CI: 1,37–3,36; p<0,01)
Confidence in the evidence
High
The highest of four GRADE levels, the effect estimate is very reliable.
Quality profile
Sample size
★★★★★
Blinding
—
Effect size
Clear benefit
Citations / year
★★★★★
Authors
Share
Abstract
Background: The use of cannabis is highly prevalent during adolescence compared to the general adult population. In addition to the high comorbidity between cannabis use and anxiety disorders, early evidence suggests that cannabis may precede the development of anxiety. Moreover, adolescence represents a major developmental period for both neurobiological and psychological processes, placing these individuals at a heightened vulnerability to the influence of cannabis.Objectives: This systematic review and meta-analysis examined the prospective associations between adolescent cannabis use and subsequent anxiety outcomes (i.e. anxiety disorders and/or symptoms).Methods: Following PRISMA guidelines, a systematic review and meta-analysis were conducted encompassing data from articles published between database inception and September 2022.Results: Six longitudinal studies were identified for quantitative analysis, while twelve non-overlapping longitudinal studies were identified for qualitative review (total N = 18; 33380 subjects). Meta-analytical findings supported an association between adolescent cannabis use and the development of a subsequent anxiety disorder (Odds Ratio = 2.14, 95% CI: 1.37-3.36, p < .01). These findings were consistent with our qualitative synthesis where nine of the twelve longitudinal studies observed a significant relationship between adolescent cannabis use and exacerbation of anxiety symptoms later in life, irrespective of an anxiety disorder diagnosis.Discussion: In summary, the current evidence suggests a prospective association between adolescent cannabis use and later anxiety symptoms and disorders. These findings underscore the importance of refining research methodologies, considering sex-based differences and controlling for confounding factors, as well as implementing educational initiatives and developing clinical interventions to address the mental health risks associated with cannabis use among adolescents.
The impediment to action advances action.